Overdiagnosis Archives - Wiser Healthcare

Breast Cancer Stage and Size Detected with Film versus Digital Mammography in New South Wales, Australia: A Population-Based Study Using Routinely Collected Data – Rachel Farber et al.

Lucia Marcello2024-04-07T16:18:13+10:00Breast cancer, Cancer, Imaging, Overdiagnosis, Publications, Screening|

Digital mammography has replaced film mammography in breast screening programs globally, including Australia. This led to an increase in the rate of detection, but whether there was increased detection of clinically important cancers is uncertain. In this population-wide retrospective cohort study in New South Wales, [...]

Effectiveness of hybrid digital breast tomosynthesis/digital mammography compared to digital mammography in women presenting for routine screening at Maroondah BreastScreen: Study protocol for a co-designed, non-randomised prospective trial – Nehmat Houssami et al.

Lucia Marcello2024-04-07T15:49:03+10:00Breast cancer, Breast density, Cancer, Imaging, Overdiagnosis, Publications, Screening|

Digital breast tomosynthesis (DBT) for breast cancer screening has been shown in international trials to increase cancer detection compared with mammography; however, results have varied across screening settings, and currently there is limited and conflicting evidence on interval cancer rates (a surrogate for screening effectiveness). [...]

Randomized Trial of Information for Older Women About Cessation of Breast Cancer Screening Invitations – Jenna Smith et al.

Lucia Marcello2024-04-07T15:44:27+10:00Ageing, Breast cancer, Cancer, Decision aids, Health literacy, Overdiagnosis, Publications, Screening, Shared decision making, Women's health|

Older women receive no information about why Australia’s breast screening program (BreastScreen) invitations cease after 74 years. We tested how providing older women with the rationale for breast screening cessation impacted informed choice (adequate knowledge; screening attitudes aligned with intention).

Health benefits and harms of mammography screening in older women (75+ years)—a systematic review – Erin Mathieu et al.

Lucia Marcello2024-04-07T15:40:26+10:00Ageing, Breast cancer, Cancer, Overdiagnosis, Overtesting, Publications, Screening, Women's health|

There is little evidence on the balance between potential benefits and harms of mammography screening in women 75 years and older. The aim of this systematic review was to synthesise the evidence on the outcomes of mammography screening in women aged 75 years and older.

Evidence for overdiagnosis in noncancer conditions was assessed: a metaepidemiological study using the ‘Fair Umpire’ framework – Sharon Sanders et al.

Lucia Marcello2024-04-07T15:30:38+10:00Overdiagnosis, Overtesting, Overuse, Publications, Research, Tests|

To our knowledge, this is the first methodological review of studies concerned with overdiagnosis in noncancer conditions. We identified 132 studies identifying or quantifying overdiagnosis of a wide range of noncancer conditions. We applied a novel framework that uses the concept of ‘‘Fair Umpires’’ to [...]

Are clinically unimportant findings qualified as benign in lumbar spine imaging reports? A content analysis of plain X-ray, CT and MRI reports – Caitlin Farmer et al.

Lucia Marcello2024-04-07T13:09:31+10:00Disease labels, Imaging, Low back pain, Musculoskeletal, Overdiagnosis, Overtreatment, Overuse, Pain, Publications, Radiology reports, Spinal|

Lumbar spine diagnostic imaging reports may cause patient and clinician concern when clinically unimportant findings are not explicitly described as benign. Our primary aim was to determine the frequency that common, benign findings are reported in lumbar spine plain X-ray, computed tomography (CT) and magnetic [...]

Benefits and harms of prostate specific antigen testing according to Australian guidelines – Michael Caruana et al.

Lucia Marcello2024-04-07T12:52:52+10:00Cancer, Overdiagnosis, Prostate cancer, Publications, Risk, Screening, Tests|

Guidelines for prostate specific antigen (PSA) testing in Australia recommend that men at average risk of prostate cancer who have been informed of the benefits and harms, and who decide to undergo regular testing, should be offered testing every 2 years from 50 to 69 years. This [...]

Gestational diabetes mellitus screening and diagnosis criteria before and during the COVID-19 pandemic: a retrospective pre–post study – Paul P Glasziou & Jenny A Doust

Lucia Marcello2024-04-05T15:49:44+11:00COVID-19, Diabetes, Disease labels, Gestational diabetes, Overdiagnosis, Publications, Screening, Women's health|

To the Editor: Meloncelli and colleagues1 have provided clear evidence that a fasting venous plasma glucose (FVPG) assessment may be used to decrease the number of unnecessary oral glucose tolerance tests (OGTTs) for low risk women. This would be a very welcome step forward. However, it does [...]

ABC News – Feminism ‘co-opted’ to market non-evidence-based women’s health interventions like AMH ‘egg timer’ tests, researchers argue

Krista Verlis2024-02-19T12:42:18+11:00News, Overdiagnosis, Overtesting, Overtreatment, Women's health|

At 38, Carla Loughnane was told she had so few eggs she was near menopause and didn't need birth control. Within six months, she was pregnant. Her twin girls were not yet two years old. This "miracle" baby was a joy, but made her doubt years [...]

The Conversation – Feminist narratives are being hijacked to market medical tests not backed by evidence

Krista Verlis2024-02-19T11:14:08+11:00News, Overdiagnosis, Overtesting, Overtreatment, Women's health|

Corporations have used feminist language to promote their products for decades. In the 1980s, companies co-opted messaging about female autonomy to encourage women’s consumption of unhealthy commodities, such as tobacco and alcohol. Today, feminist narratives around empowerment and women’s rights are being co-opted to market interventions [...]

Overdiagnosis

Staff Intranet